Cancer Research UK (CRUK) shared on LinkedIn:
“We’re pleased to announce Professor Mariam Jamal-Hanjani as our new Chief Clinician!
As our senior clinical research advisor, the chief clinician combines clinical research leadership with specialist scientific advice to help us further our goal of beating cancer.
Mariam is Professor of Cancer Genomics and Metastasis at UCL Cancer Institute.
She’s led on recent key research initiatives like TRACERx, TRACERx EVO, the PEACE research autopsy programme, and the first in-human LungVax lung cancer prevention vaccine trial.
Mariam succeeds Professor Charles Swanton in the role, who’s provided essential scientific and clinical leadership to Cancer Research UK for the last nine years – thank you, Charlie, for your vital support of our mission.
Please join us in welcoming Mariam to the role!”
Cancer Research UK appoints Professor Mariam Jamal-Hanjani as its new chief clinician
To which Michelle Mitchell, Chief Executive at Cancer Research UK, added:
“Great to be able to share this news.
Mariam’s leadership on some of our key research programmes, as well as her wider scientific and clinical knowledge and understanding of the challenges research orgs face, puts her in a great place to help us beat cancer for everyone.
And of course, we owe a huge thank you to Professor Charles Swanton – our outgoing chief clinician – for your support of our mission over the last 9 years.
Thank you, Charlie!”
Other articles about CRUK on OncoDaily.